Drug Approval | March 23, 2022
Covovax for teens get DCGI nod
It is the fourth vaccine to get the nod for 12 years and older after Biological E’s Corbevax, Bharat Biotech’s Covaxin and Zydus Lifesciences Zy-CoV-D
It is the fourth vaccine to get the nod for 12 years and older after Biological E’s Corbevax, Bharat Biotech’s Covaxin and Zydus Lifesciences Zy-CoV-D
Submissions for Ruminant Well-Being Awards and Gustav Rosenberger Memorial Fund grant open now
Sputnik Light is the first component of Sputnik V
Augnito in association with Japanese company Fujifilm enables voice recognition within their radiology information system platform
The announcement follows recent authorization of the Company's mRNA COVID-19 vaccine in Australia and the European Union for children aged 6-11 years
The Karnataka Health Promotion Trust held a day-long session in New Delhi to address health care challenges
The facility will enable research initiatives in analytical chemistry, biopharmaceuticals, and life sciences
Clinical surveillance solution is designed to identify emergent patient deterioration and offer enhanced patient data visibility, flexible viewing options, and clinical decision support
SIFI is currently evaluating various options for the commercialization of Akantior (polihexanide) globally, including potential out-license agreements outside its core markets
The single in vitro diagnostic test helps inform therapy decisions according to clinical guidelines to enable precision medicine earlier in the disease journey
Subscribe To Our Newsletter & Stay Updated
